Dipexium announces closing of public offering of common stock
Dipexium announced the closing of its previously announced underwritten public offering of 1,480,000 shares of common stock. The underwriters exercised their over-allotment option in full to purchase an additional 222,000 shares of common stock. Net proceeds are expected to be $19.7 million. June 30, 2015